Large coalition joins drug lobby in denouncing Trump proposal to import drug prices for Medicare
Trump’s October proposal to peg drug prices to overseas rates for Medicare beneficiaries has elicited the ire of not just the all-powerful biopharma lobby, but …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
